Zhejiang University School of Medicine Second Affiliated Hospital Successfully Completes First-in-Nation Clinical Procedures Using AcoMed's PFA System
AccuPulse
Developer of products in the field of cardiac electrophysiology
Recently, the Boao Campus of the Second Affiliated Hospital of Zhejiang University School of Medicine, as one of the first clinical application units in China, byThe electrophysiology expert team led by Wang Jian'an, Academician and President of Zhejiang University Second Hospital & Deputy Secretary of the Party Committee, and Professor Fan YouqiApplication of AccuPulse Medical®Disposable Cardiac Pulse Electric Field Ablation Catheter and AccuBlator®AccuPulse successfully performed cardiac pulse field ablation (PFA) surgery on two patients with atrial fibrillation.
The successful completion of the two surgeries not only marks the formal entry of this innovative domestically-produced PFA system into the clinical application stage, but also, with its three core advantages of integrated circular catheter mapping and modeling, efficient ablation, and excellent safety, provides a better option for atrial fibrillation interventional treatment.
Case Summary
CASE1 Male, 70 years old, weight 86kg, paroxysmal atrial fibrillation (with hypertrophic cardiomyopathy);
CASE2 Male, 43 years old, weight 67kg, paroxysmal atrial fibrillation;
The two surgeries were controlled within 3.5 hours from preparation to completion, with a total ablation time of only 1 minute and 23 seconds, achieving 100% pulmonary vein isolation during the procedure.Through AccuPulse's self-developed impedance contact prompting technology and flexible electrode selection for discharge, clinical procedures can target specific areas with energy delivery based on a well-contacted foundation and ablation strategy, ensuring effectiveness while avoiding excessive ablation.The surgery went smoothly, and the patient recovered well post-operation, having been discharged successfully.AccuPulse Medical Cardiac Pulse Ablation SystemProvides a safer, more effective, and less invasive treatment option for patients with atrial fibrillation.
AccuPulse MedicalCardiac Pulse Ablation SystemOne of the core advantages lies in its circular catheter design, which integrates mapping modeling and ablation functions.This catheter can efficiently construct a three-dimensional electroanatomical model of the heart during surgery and precisely locate lesions. This design eliminates the need for an additional high-density mapping catheter in traditional procedures, not only streamlining the surgical process and reducing operational complexity but also directly saving considerable costs associated with high-value consumables. Additionally, the 7.5F slim-tube design effectively minimizes tissue damage. The optimized energy formulation ensures treatment efficacy while improving patient tolerance. Anesthesia strategies can be flexibly tailored according to the habits of operators at each center. Intelligent contact sensing and flexible electrode pairing make the procedure more manageable for surgeons.
Expert Commentary
Professor Fan Youqi gave high praise for the debut performance of the AccuPulse PFA system:AccuPulse®The integrated design of the disposable cardiac pulsed field ablation catheter significantly optimizes the surgical process, with its highly efficient ablation capability and outstanding safety being impressive. This successful application also marks an important step in our exploration of better atrial fibrillation treatment solutions to benefit a wide range of patients. Its efficiency, safety, and potential cost-saving advantages offer broad prospects for clinical application.
AccuPulse will continue to invest in research and development and clinical validation, deepen clinical cooperation with the Second Affiliated Hospital of Zhejiang University, promote the standardized application and popularization of PFA technology, and strive to provide internationally leading one-stop atrial fibrillation diagnosis and treatment solutions for patients with arrhythmia in China.
About AccuPulse Medical
AccuPulse Medical Technology Co., Ltd. is an innovative enterprise based in Suzhou that focuses on the research, development, and industrialization of cutting-edge technologies in the field of cardiac electrophysiology. The company’s core team possesses deep expertise in electrophysiological technology and extensive experience in the industrialization of medical devices, consistently striving to provide safer, more efficient, and more convenient treatment options for patients with arrhythmias such as atrial fibrillation. This time, AccuPulse®Single-use Cardiac Pulsed Field Ablation Catheter and AccuBlator®The successful clinical application of the cardiac pulsed electric field ablation system marks a milestone in the company's progress in innovative electrophysiological treatment technology.
AccuPulse's newly approved single-use cardiac pulsed field ablation catheter has overcome the challenges of stability and anatomical adaptability in PFA ablation catheters, providing a precise and reliable solution for pulmonary vein isolation (PVI). AccuPulse®The unique 7.5F adjustable loop diameter design of the circular pulsed ablation catheter flexibly adapts to pulmonary vein ablations with different anatomical structures. Intelligent contact indication and flexible electrode selection give operators complete control, enabling precise pulsed ablation!
01 Finer: 7.5F ultra-fine catheter, reducing tissue damage
02 More Stable: Intelligent Docking Prompt for More Precise Operation
03 More Flexible: Adjustable loop diameter (15-20mm or 20-25mm) to meet different clinical choices.
Bao'ao Campus of the Second Affiliated Hospital of Zhejiang University School of Medicine
The Boao Campus of the Second Affiliated Hospital of Zhejiang University is an important branch of the Second Affiliated Hospital of Zhejiang University School of Medicine. Relying on the strong comprehensive strength and discipline advantages of the parent hospital, it is committed to building a high-level clinical diagnosis and treatment, medical research, and transformation platform. Its Department of Cardiovascular Medicine holds a leading position in China in the field of interventional diagnosis and treatment of arrhythmias, continuously introducing and validating cutting-edge technologies from around the globe to provide high-quality medical services for patients. The campus’s recent designation as one of the first clinical application sites in China for AccuPulse’s PFA system also highlights both parties' active exploration of innovative technologies in the field of cardiac electrophysiology.
Expert Profile
Wang Jian'an
The Second Affiliated Hospital of Zhejiang University School of Medicine(View expert's detailed resume by clicking)
Fan Youqi
The Second Affiliated Hospital of Zhejiang University School of Medicine(View expert's detailed resume by clicking)
